Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates. Its structure incorporates a fluoromethyl group on an azetidine ring, which can enhance metabolic stability and influence binding affinity in medicinal chemistry. Commonly employed in the preparation of protease inhibitors and receptor modulators due to the ring strain and polarity of the azetidine core. Also utilized in agrochemical research for designing novel active ingredients with improved physicochemical properties.